Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation. - Wikidata - awgldk - TriplyDB

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

http://www.wikidata.org/entity/Q35212696

about

Noonan syndrome Paraspinal neurofibromas and hypertrophic neuropathy in Noonan syndrome with multiple lentigines.Network-Based Integration of Disparate Omic Data To Identify "Silent Players" in Cancer Risk of Neoplasia in Pediatric Patients Receiving Growth Hormone Therapy--A Report From the Pediatric Endocrine Society Drug and Therapeutics Committee.In silico analyses reveal common cellular pathways affected by loss of heterozygosity (LOH) events in the lymphomagenesis of Non-Hodgkin's lymphoma (NHL).Noonan syndrome.Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population.K-RasV14I recapitulates Noonan syndrome in mice.Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes New Genetic Insights into Congenital Heart Disease.Five-year response to growth hormone in children with Noonan syndrome and growth hormone deficiency.Syndrome-Associated Tumors by Organ System.Genetic predispositions to childhood leukemia.Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.The role of the RAS pathway in iAMP21-ALL.Noonan syndrome - a new survey.Malignancy in Noonan syndrome and related disorders.Occurrence of Cranial Neoplasms in Pediatric Patients with Noonan Syndrome Receiving Growth Hormone: Is Screening with Brain MRI prior to Initiation of Growth Hormone Indicated?Molecular Diversity and Associated Phenotypic Spectrum of Germline CBL Mutations.Optic nerve pilomyxoid astrocytoma in a patient with Noonan syndrome.Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.Occurrence of DNET and other brain tumors in Noonan syndrome warrants caution with growth hormone therapy.Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.The third international meeting on genetic disorders in the RAS/MAPK pathway: towards a therapeutic approach.K-Ras(V14I) -induced Noonan syndrome predisposes to tumour development in mice.Update on Genetic Conditions Affecting the Skin and the Kidneys.Medulloblastoma in a patient with the PTPN11 p.Thr468Met mutation.Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis Multiple, diffuse schwannomas in a RASopathy phenotype patient with germline KRAS mutation: a causal relationship?

P2860

Q27001641-AB083609-D32D-4ED0-B7B8-610FDAD06D0E Q30278754-1E2475FE-3E63-4C21-83ED-89A53EDB284A Q31032861-1007F853-8CCC-4EC7-BB37-71DB5245A7FF Q33570283-C043488B-4598-41E6-BB90-CF119BFD9DA6 Q33701036-4BAF0E83-B527-4191-A3B1-E62DE1ACDE93 Q33904939-BF4DCBA6-AFFD-435E-AFC6-A0FCE2D385EE Q34334450-60432735-CF29-4C16-84BF-15BF3682A9BA Q34581270-3EBCA55B-A981-4022-8243-5C4FE56F6623 Q35475470-FF2C591F-6A48-49E7-AA89-2E986BFFF2F3 Q36106143-5D24B70E-B793-4BAC-975D-F782F4A28C1F Q36127065-332D8A92-B992-4CA6-A245-B05196D926CF Q37032662-592369E2-E461-4432-8E43-B707E849946F Q37073895-3BD5F764-B37E-4D17-BED3-83A704A6C439 Q37212868-9648FA06-FBCD-4A85-BB54-912853B051CB Q37245131-0FCDE3D8-62CE-4637-B036-79778A4D49C9 Q37549407-8543501F-7BE4-48C2-897B-64F5F355D1E9 Q38356240-8C935E34-AB9B-43AC-B8D9-D1D63B157D64 Q48178392-EF0E2BC9-514E-4674-92C7-D1D627D1653B Q50587974-33F4F387-1E78-4F43-A290-E76E272AC611 Q50607668-810D2D51-6CDB-467E-BD7F-B1701A6782E1 Q52101515-C89E2F72-5E9C-4BE0-B264-A166B8C8C3D2 Q52149150-5AC69FB4-2B83-41F9-94FD-40ECBFC24DC6 Q52793910-B7690643-8B21-4C7D-95B4-D03EABA1B7BE Q53072085-F2E713E4-97DD-4DD4-8008-500A80F564FA Q53101926-1DBA10CA-5D18-4F5D-8C7F-EA6E0D66F893 Q55140325-B61E7E57-F73B-4CA3-8613-9C31DFB203F1 Q55461559-C490CC43-F160-480D-9C47-5426A44622FB Q56770882-504A0D4C-CE07-4514-B4BC-1365A9A0EC7D Q57234950-776E48FE-159D-4DD9-9714-858805FD4BF6

P2860

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

http://www.wikidata.org/entity/Q35212696

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@ast

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@en

type

label

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@ast

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@en

prefLabel

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@ast

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

@en

P1433

Q35212696-EE2B02A9-07E1-4154-B77A-54897176E6E9

P1476

Q35212696-C2DF2E38-8FFF-4B9C-9C9D-A27955C549C7

P2093

Q35212696-2E42F56C-19AC-4AB8-B7BD-C94101BFD6B3

Q35212696-3CDE4CFD-2504-4452-962B-7F0A4A220021

Q35212696-5044BA6B-9D58-4982-9E73-0ABF9AF89FE2

Q35212696-71274AC5-9C75-4755-9596-0E798BCD4DF7

Q35212696-8061E56E-B49C-49F9-9108-0060DCDBBDE9

Q35212696-93078055-3126-44EC-9B84-2B4A30493B5D

Q35212696-9B8E3868-D0C5-43E8-9D12-743A4E2A90B9

Q35212696-A46F7CCC-08A0-4E60-B845-F9044E9147AF

Q35212696-F46F87DA-6682-4124-81D4-66C214474D8A

P2860

Q35212696-13BC9893-436B-43EC-BFDE-570A0B5821FA

Q35212696-29C912B8-CB0A-404B-A79C-8C841ACBFD07

Q35212696-2D354F12-5847-4892-98A4-52C010A210E7

Q35212696-2DE2F733-EA1B-47B2-B14F-C78CD8560A9D

Q35212696-3EFD76FF-80BF-4F06-9065-E9AA0AEBA944

Q35212696-408A3BFD-F11A-4C37-A620-2C5266799712

Q35212696-427D8266-1C3D-4D5F-8303-8B02720473DE

Q35212696-5A0B9628-98F1-41A5-BAFF-E6B451010434

Q35212696-5B3C71DD-2A98-43ED-B5A1-355B2714D39D

Q35212696-5F2A26D8-F4EE-4599-B5BE-94ED5A817949

P2888

Q35212696-0B78BB45-74C4-4BB0-BF10-23B0DF1DDD2B

P304

Q35212696-60313B77-E095-4BCA-8491-395214D716D6

P31

Q35212696-4283A283-BFE1-484C-9A1B-E19298CFEB67

P356

Q35212696-9A7F2516-D95B-4FC9-9ABD-397130943956

P407

Q35212696-25707E19-177F-4469-A142-0D51A1601E2F

P433

Q35212696-211A83BE-E7B3-430E-B666-BD1E0B3E663C

P478

Q35212696-0336C68A-7184-494D-9C96-A4C6C6057682

P50

Q35212696-8A202671-8F10-4F0B-A634-C0BF8E3C7E6F

Q35212696-92E48180-929F-4C00-82F0-D4C6DB0C4720

Q35212696-D8F5493C-CC6A-4EE7-9990-42288E1DD162

P577

Q35212696-AA892970-E836-4515-AC4D-6EBBFA89F0DA

P5875

Q35212696-4BAE9709-E6D3-4204-9B13-1C4BAE8837C4

P698

Q35212696-8742790D-6EFD-44C5-BFB9-8FF1FE34E840

P932

Q35212696-04224507-4252-4D10-AECB-91F90788FAEB

P356

P1433

European Journal of Human Genetics

P1476

Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation

@en

P2093

Ad Geurts van Kessel

http://www.w3.org/2001/XMLSchema#string

Helger G Yntema

http://www.w3.org/2001/XMLSchema#string

Ineke van der Burgt

http://www.w3.org/2001/XMLSchema#string

Marjolijn C J Jongmans

http://www.w3.org/2001/XMLSchema#string

Marjolijn J L Ligtenberg

http://www.w3.org/2001/XMLSchema#string

Nicoline Hoogerbrugge

http://www.w3.org/2001/XMLSchema#string

Peter M Hoogerbrugge

http://www.w3.org/2001/XMLSchema#string

Roland P Kuiper

http://www.w3.org/2001/XMLSchema#string

Willy M Nillesen

http://www.w3.org/2001/XMLSchema#string

P2860

Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease.

Genetic alterations during colorectal-tumor development

Does growth hormone cause cancer?

Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia

Transient abnormal myelopoiesis in Noonan syndrome.

Juvenile myelomonocytic leukemia and Noonan syndrome.

Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature.

Occurrence of myeloproliferative disorder in patients with Noonan syndrome.

Vaginal rhabdomyosarcoma in a patient with Noonan syndrome

Noonan syndrome: clinical aspects and molecular pathogenesis.

P2888

P304

870-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EJHG.2011.37

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Lambertus Kiemeney

Han van Krieken

P577

2011-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50399254

http://www.w3.org/2001/XMLSchema#string

P698

21407260

http://www.w3.org/2001/XMLSchema#string

P932

3172922

http://www.w3.org/2001/XMLSchema#string